Sterling Diagnostic Imaging taps chairman Rodney Wolford as president and CEO.
This article was originally published in The Gray Sheet
STERLING DIAGNOSTIC'S NEW CHIEF RODNEY WOLFORD is charged with overseeing the company's transition from conventional film-based imaging to digital imaging systems. Wolford, who has served as Sterling's chairman since April 1, assumed president and CEO duties effective Aug. 1.
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.